A detailed history of Miller Financial Services LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Miller Financial Services LLC holds 25,000 shares of CTMX stock, worth $21,000. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,000
Holding current value
$21,000
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$0.86 - $1.29 $21,500 - $32,250
25,000 New
25,000 $25.8 Million

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $55.4M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Miller Financial Services LLC Portfolio

Follow Miller Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Financial Services LLC with notifications on news.